Gene · 10499
Papers3,077
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,077
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond the Globe: Molecular Diagnostics of Optic Nerve, Orbital, and Adnexal Neoplasms. | Transl Vis Sci Technol | 2026 | 41769942 | PubTator, text mining | PubMed |
| Case Report: Hybrid low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma of the retroperitoneum. | Front Oncol | 2026 | 41768229 | PubTator, text mining | PubMed |
| From prostate specific antigen to genomic signatures: Advances in biomarkers for prostate cancer diagnosis and prognosis. | Transl Oncol | 2026 | 41762538 | PubTator, text mining | PubMed |
| Epigenetic, Genetic, and Functional Germline Alterations of PAX Genes in Human Pathology: A Comprehensive Update. | Curr Issues Mol Biol | 2026 | 41751498 | PubTator, text mining | PubMed |
| From Gas Chromatography-Mass Spectrometry (GC-MS) to Network Pharmacology: System-Level Insights into the Multi-Target Biological Potential of Flaveria trinervia (Spreng.) C. Mohr. | Curr Issues Mol Biol | 2026 | 41751423 | PubTator, text mining | PubMed |
| Integrated Single-Cell and Spatial Transcriptomics Coupled with Machine Learning Uncovers MORF4L1 as a Critical Epigenetic Mediator of Radiotherapy Resistance in Colorectal Cancer Liver Metastasis. | Biomedicines | 2026 | 41751172 | PubTator, text mining | PubMed |
| Hypoxia, ROS, and HIF Signaling in I/R Injury: Implications and Future Prospects. | Antioxidants (Basel) | 2026 | 41750534 | PubTator, text mining | PubMed |
| Nuclear Receptor-Targeted Therapies: Reprogramming Metabolism with TRβ, ERRα, and LXR Modulators. | Biomolecules | 2026 | 41750342 | PubTator, text mining | PubMed |
| The Development of Novel Treatment Strategies for Rhabdomyosarcoma. | Cancers (Basel) | 2026 | 41749943 | PubTator, text mining | PubMed |
| Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) With a GREB1-NCOA2 Fusion: A Case Report and Diagnostic Considerations. | J Obstet Gynaecol Res | 2026 | 41740988 | PubTator, text mining | PubMed |
| Emerging therapies to overcome antiandrogen resistance and beyond in lethal prostate cancer. | J Natl Cancer Cent | 2026 | 41738039 | PubTator, text mining | PubMed |
| Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer. | J Natl Cancer Cent | 2026 | 41738031 | PubTator, text mining | PubMed |
| DNA induces non-canonical dimerization of the farnesoid X receptor. | Nucleic Acids Res | 2026 | 41728955 | PubTator, text mining | PubMed |
| Evolutionary Integration and Glucocorticoid Regulation of the Respiratory System: Structure, Function, and Homeostatic Adaptation. | Med Sci (Basel) | 2026 | 41718137 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomisation identifies causal links between blood proteins and myopia. | J Glob Health | 2026 | 41718003 | PubTator, text mining | PubMed |
| Optimization of potential targets for antidepressant Chinese medicines: AI and multi-omics methods. | Chin Med | 2026 | 41668206 | PubTator, text mining | PubMed |
| Repurposing nuclear receptors for ligand-responsive liquid condensate formation and gene regulation. | Nat Commun | 2026 | 41620421 | PubTator, text mining | PubMed |
| Describing the Mutational Characteristics of Myxofibrosarcoma: An AACR Project GENIE Analysis. | Anticancer Res | 2026 | 41617429 | PubTator, text mining | PubMed |
| The metabolic dysfunction-associated steatohepatitis (MASH) drug resmetirom exhibits broad nuclear receptor activity with minimal functional impact. | Sci Rep | 2026 | 41611794 | PubTator, text mining | PubMed |
| Oligoclonal B cell expansion and passenger fusion genes predict response to Nivolumab in recurrent ovarian cancer: phase II Kyoto trial. | Cancer Immunol Immunother | 2026 | 41591474 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10499/papers?page=2